Ph3 study comparing CC-92480 in subjects with RRMM (SUCCESSOR-1)
Phase III Clinical Trial
A Phase 3 Two-Stage Randomized Multicenter Open-Label Study Comparing Mezigdomide (CC-92480) Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide Bortezomib and Dexamethasone (PVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM):Successor-1 (CA057-001)